期刊文献+

脑钠肽与不稳定型心绞痛患者左心功能相关性研究 被引量:7

Relationship between brain natriuretic peptide and left heart function in patients with unstable angina pectoris
下载PDF
导出
摘要 目的研究血浆脑钠肽(BNP)水平与左心室舒张末期压力(LVEDP)在不稳定型心绞痛(UAP)患者中的变化规律,探讨左心功能的变化与BNP变化的相关性。方法选择57例冠状动脉造影(CAG)检查者为研究对象,CAG检查正常者12例作为对照组,45例UAP患者按Braunwald分级分为Ⅰ级组(16例)、Ⅱ级组(14例)和Ⅲ级组(15例)。所有患者采用多普勒超声心动图检测左心房前后径(LAD)、左心室舒张末期内径(LVEDd)、左心室后壁厚度(LVPWT)、室间隔厚度(IVST)、左心室射血分数(LVEF)及E/A数值。通过左心室压力曲线测左心室舒张末期压力(LVEDP)。用酶联免疫吸附定量法测BNP的浓度。结果对照组、Ⅰ级组、Ⅱ级组、Ⅲ级组BNP和LVEDP水平组间两两比较差异均有统计学意义(P<0.05);其余各指标组间两两比较差异均无统计学意义(P>0.05)。BNP水平与LVEDP有明显的相关性(r=0.756,P<0.01)。结论 BNP可反映UAP患者心肌缺血的程度,在一定范围内可反映充血性心力衰竭的严重程度。 Objective To observe the changing rule of plasma level of brain natriuretic peptide(BNP) and left ventricular end-diastolic pressure(LVEDP)in patients with unstable angina pectoris(UAP),and explore the correlation between the changes of left heart function and BNP. Methods Fifty-seven cases who underwent coronary angiography(CAG) examination were included.Twelve cases with normal CAG examination results as control group,forty-five patients with UAP were divided into grade Ⅰ group(n=16),grade Ⅱ group(n=14) and grade Ⅲ group(n=15) according to the class of Braunwald.The left atrial diameter(LAD),left ventricular end-diastolic diameter(LVEDd),left ventricular posterior wall thickness(LVPWT),interventricular septal thickness(IVST),left ventricular ejection fraction(LVEF)and E/A were detected in all cases by Doppler echocardiography.The value of LVEDP was detected by record left ventricular pressure curves in all cases.The plasma concentration of BNP was measured by radioimmunoassay. Results There were significant differences in the plasma levels of BNP and LVEDP in control group,grade Ⅰ,Ⅱ,Ⅲ groups(P0.05);the other indexes had no statistic difference in groups(P0.05).The plasma level of BNP was obviously correlated with LVEDP in all cases(r= 0.756,P0.01). Conclusion The level of BNP could reflect the severity of cardiac ischemia in patients with UAP,it could reflect the severities of congestive heart failure to some extend.
作者 杨波 夏勇
出处 《新乡医学院学报》 CAS 2012年第6期434-436,共3页 Journal of Xinxiang Medical University
关键词 脑钠肽 左心室舒张末期压力 左心导管 不稳定型心绞痛 充血性心力衰竭 brain natriuretic peptide left ventricular end-diastolic pressure left cardiac catheter unstable angina pectoris congestive heart failure
  • 相关文献

参考文献8

  • 1Goto T, Takase H, Toriyama T, et al. Circulating concentrations of cardiac proteins indicate the severity of congestive heart failure [J]. Heart,2003,89( 11 ) :1303-1307.
  • 2Vanderheyden M, Vrints C, Verstreken S, et al. B-type natriuretic peptide as a marker of heart failure : new insights from biochemistry and clinical implications [ J ]. Biomark Med, 2010,4 ( 2 ) : 315 -320.
  • 3Xia W J,Huang Y Y, Chert Y L,et al. Acute myocardial ischemia directly modulates the expression of brain natrinretic peptide at the transcriptional and translational levels via inflammatory eytokines [J]. Eur J Pharmacol,2011,670( 1 ) :7-12.
  • 4陈炤炤,齐国先,贾大林.用介入方法获得的两个参数在评价左心室舒张功能中的应用[J].中国循环杂志,2003,18(1):22-24. 被引量:6
  • 5Pramote P, Pronwalee P, Hendrik H, et al. B-type natriuretic pep- tide-guided heart failure therapy [ J ]. Arch Intern Med, 2010,170 (6) :507-514.
  • 6曹雅旻,胡大一,闫丽.急性冠状动脉综合征严重程度与血浆氨基酸N末端脑钠肽原浓度相关性的研究[J].中华心血管病杂志,2005,33(10):899-902. 被引量:60
  • 7Masson S, Latini R, Anand l S, et al. Direct comparison of B-type natriuretic peptide(BNP) and anlino-terminal pro-BNP in a large population of patients with chronic and symptomatic heart failure : the Valsartan Heart Failure (Val-HeFF) data [ J ]. Clin Chem, 2006,52 ( 8 ) : 1528-1538.
  • 8王宏雁.曲美他嗪治疗慢性缺血性心肌病心力衰竭[J].新乡医学院学报,2010,27(2):176-178. 被引量:4

二级参考文献30

  • 1赵艳芳,秦永文,王学敏,缪明永.曲美他嗪对大鼠缺血再灌注心肌线粒体的保护作用[J].医学研究生学报,2005,18(B05):11-13. 被引量:10
  • 2陶智虎,方五旺.曲美他嗪对慢性稳定型心绞痛患者的疗效评价[J].实用临床医药杂志,2006,10(3):87-87. 被引量:4
  • 3Cheung BMY, Kumana CR. Nariuretic peptides-relevance in cardiac disease. JAMA, 1998,280:1983-1984.
  • 4Etsuo M, Hirofumi Y, Michihiro Y, et al. Increased plamsma levels of brain natriuritic peptide in patients with acute myocardial infarction. Circulation, 1993,88:82-91.
  • 5Dicstein K. Natriuretic peptides in detection of heart failure. Lancet, 1998,35: 3-4.
  • 6Clerico A, Iervasi G, Chicca M, et al. Circulating levels of cardiac natriuretic peptides (ANP and BNP) measured by highly sensitive and specific immunoradiometric assays in normal subjects and in patients with different degrees of heart failure. J Endocrinol Invest, 1998,21: 170-179.
  • 7Maisel A. B-type natriuretic levels: a potential novel "White count" for congestive heart failure. J Cardiac Fail, 2001, 7: 183-193.
  • 8Brandt RR, Burnett Jr. Humoral control of the kidney during congestive heart failure: role of cardiac natriuretic peptides and angiotensin II. In: Poole-Wilson PA, Colucci WS, Massie BM, eds. Heart Failure. New York: Churchill Livingstone, 1997.143-154.
  • 9Mair J, Hammerer-lercher A, Puschendorf B. The impact of cardiac natriuretic peptide determination on the diagnosis and management of heart failure. Clin Chem Lab Med, 2001, 39:571-588.
  • 10Talwar S, Squire IB, Downie PF, et al. Plasma N terminal pro-brain natriuretic peptide and cardiotrophin 1 are raised in unstable angina. Heart, 2000,84:421-424.

共引文献66

同被引文献61

  • 1徐晤,夏勇,陈建辉,吴建东,张超群,杨煜,潘德锋,徐通达,郭密娟.左室测压和造影对冠心病介入治疗前后左心室功能变化的评价[J].临床心血管病杂志,2006,22(2):116-117. 被引量:2
  • 2柯元南,陈纪林.不稳定性心绞痛和非ST段抬高心肌梗死诊断与治疗指南[J].中华心血管病杂志,2007,35(4):295-304. 被引量:2125
  • 3Vanderheyden M, Vrints C, Verstreken S, et al. B-type natriuretic peptide as a marker of heart failure : new insights from biochemistry and clinical implications[ J]. Biomark Med,2010,4 (2) :315-320.
  • 4Fares N, Nader L, Saliba Y,et al. B-type natriuretic peptide modu- lates the action potential and the L-type calcium current in adult rat heart muscle cells[ J]. J Med Liban,2010,58(4) :222-227.
  • 5Fox K A,Anderson F A,Dabbous O H,et al. Intervention in acute coronary syndromes:do patients undergo intervention on the basis of their risk characteristics? The global registry of acute coronary e- vents(GRACE) [J]. Heart,2007,93 (2) :177-182.
  • 6Galvani M, Ferrini D, Ottani F. Natriuretic peptides for risk stratifi- cation of pati~ ,,ts with acute coronary syndromes[J]. Eur J Heart Fail ,2004,6 ( 3 ) :327-333.
  • 7Guidez T, Marechaux S, Pincon C,et al. Addition of B-type natri- uretie peptide to the GRACE score to predict outcome in acute coronary syndrorne:a retrospective(development) and prospective (validation) cohort-based study [ J ]. Emerg Med J, 2012,29 ( 4 ) : 274-279.
  • 8Ang D S, Wei L, Kao M P, et al. A comparison between B-type natriuretie peptide, global registry of acute coronary events (GRACE) score and their combination in ACS risk stratification [ J ]. Heart,2009,95 ( 22 ) : 1836-1842.
  • 9王毅.甲状腺疾病[M].北京:人民卫生出版社,1998:109.
  • 10Franklyn JA, Boelaert K. Thyrotoxicosis [ J ]. Lancet, 2012,379 ( 9821 ) : 1155-1166.

引证文献7

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部